SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000950170-23-052416
Filing Date
2023-10-06
Accepted
2023-10-06 16:30:52
Documents
25

Document Format Files

Seq Description Document Type Size
1 S-3 acst-20231006.htm   iXBRL S-3 595563
2 EX-4.1 acst-ex4_1.htm EX-4.1 413661
3 EX-5.1 acst-ex5_1.htm EX-5.1 24870
4 EX-23.1 acst-ex23_1.htm EX-23.1 4424
5 EX-23.2 acst-ex23_2.htm EX-23.2 5913
6 EX-FILING FEES acst-exfiling_fees.htm EX-FILING FEES 97003
7 GRAPHIC img136875453_0.jpg GRAPHIC 17299
8 GRAPHIC img136875453_1.jpg GRAPHIC 7788
9 GRAPHIC img136875453_2.jpg GRAPHIC 7788
10 GRAPHIC img180443758_0.jpg GRAPHIC 10406
11 GRAPHIC img180443758_1.jpg GRAPHIC 4473
12 GRAPHIC img206583140_0.jpg GRAPHIC 9469
13 GRAPHIC img206583140_1.jpg GRAPHIC 3444
  Complete submission text file 0000950170-23-052416.txt   1474960

Data Files

Seq Description Document Type Size
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acst-20231006_lab.xml EX-101.LAB 13401
15 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT acst-20231006_def.xml EX-101.DEF 11408
16 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acst-20231006.xsd EX-101.SCH 2911
17 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acst-20231006_pre.xml EX-101.PRE 11250
19 EXTRACTED XBRL INSTANCE DOCUMENT acst-20231006_htm.xml XML 6469
Mailing Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5
Business Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5 450-686-4555
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: S-3 | Act: 33 | File No.: 333-274899 | Film No.: 231314568
SIC: 2834 Pharmaceutical Preparations